Information Mitoquinone (MitoQ10) mesylate Mitoquinone mesylate (MitoQ, MitoQ10, Mitoubiquinone) is a TPP-based, mitochondria -targeted antioxidant that blocks H 2 O 2 -induced intracellular ROS responses and protects against oxidative damage. This product is a waxy solid. Targets mitochondria ; ROS In vitro Mitoquinone blocks H2O2-induced intracellular ROS responses inmurine pancreatic acinar cells. Mitoquinone does not reduce mitochondrial depolarisation induced by either cholecystokinin (CCK) or bile acid TLCS. Mitoquinone increases basal and CCK-induced cell death in a plate-reader assay. In vivo In a TLCS-induced AP model Mitoquinone treatment is not protective. In AP induced by caerulein hyperstimulation (CER-AP), Mitoquinone exerts mixed effects. Thus, partial amelioration of histopathology scores is observed but without reduction of the biochemical markers pancreatic trypsin or serumamylase. Lungmyeloperoxidase and interleukin-6 are concurrently increased by Mitoquinone in CER-AP. Mitoquinone causes biphasic effects on ROS production in isolated polymorphonuclear leukocytes, inhibiting an acute increase but elevating later levels. Cell Research(from reference) Cell lines：Pancreatic Acinar Cells Concentrations：1 μM, 10 μM Incubation Time：200 s, 400 s, 600 s, 800 s, 1000 s